Analysts expect Denali Therapeutics Inc (NASDAQ:DNLI) to post sales of $287.35 million for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Denali Therapeutics’ earnings. The lowest sales estimate is $4.00 million and the highest is $565.99 million. Denali Therapeutics reported sales of $13.60 million during the same quarter last […]
